Summary
Lonidamine (LND) has been shown to inhibit tumor aerobic glycolysis. Its effect was evaluated on several human astrocytomas at different degrees of malignancy; a correlation was found between LDN effect on lactate production and tumor malignancy: in grade I and II astrocytomas LND stimulates lactate production, while in grade III, IV and glioblastoma multiforme lactate production is inhibited.
In an attempt to explain this different behaviour, hexokinase content and compartmentation was evaluated in astrocytomas from fresh operatory specimens and from cultured cells as well, observing a significative correlation between malignancy, hexokinase activity, percent of mitochondrially-bound hexokinase and LND effect.
The results justify from a biochemical point of view the role of LND as a ‘non-conventional’ agent in multimodality combined treatment for malignant gliomas.
Similar content being viewed by others
References
Burk D, Wood M, Hunter J: On the significance of glucolysis for cancer growth, with special references to Morris rat hepatomas. J Natl Cancer Inst 38:839–863, 1967
Warburg O: The metabolism of tumors. Constable, London, 1930
Warburg O: On the origin of cancer cells. Science (Wash DC) 123:309–314, 1956
Pedersen PL: Tumor mitochondria and bioenergetics of cancer cells. Prog Exp Tumor Res 22:190–274, 1978
Wenner CE: Regulation of energy metabolism in normal and tumor tissue, in: Becker FF (ed) Cancer, a comprehensive treatise, Plenum Publ Corp, New York, 1975, vol 3, pp 389–403
Suolinna EM, Bushbaum RN, Racker E: The effect of flavonoids on aerobic glycolysis and growth of tumor cells. Cancer Res 35:1865–1872, 1975
Suolinna EM, Lang DR, Racker E: Quercetin, an artificial regulator of the high aerobic glycolysis of tumor cells. J Natl Cancer Inst 53:11515–11519, 1974
Graziani Y: Bioflavonoid regulation of ATPase and hexokinase activity in Ehrlich ascites tumor mitochondria. Biochem Biophys Acta 460:364–373, 1977
Hume DA, Weidemann MJ: Role and regulation of glucose metabolism in proliferating cells.. J Natl Cancer Inst 62:3–9, 1979
Racker E: Bioenergetics and the problem of tumor growth. Amer Sci 60:56–63, 1972
Scholnick P, Land D, Racker E: Regulatory mechanisms in carbohydrate metabolism. IX Stimulation of aerobic glycolysis by energy-linked ion transport and inhibition by dextran sulphate. J Biol Chem 248:5175–5182, 1973
Floridi A, De Martino C, Marcante ML, Apollonj-Ghetti C, Scorza-Barcellona P, Silvestrini B: Morphological and biochemical modifications of rat germ cells mitochondria induced by new antispermatogenic compounds. Exp Mol Path 35:314–331, 1981
Floridi A, Lehninger AL: Action of the antitumor and antispermatogenic agent Lonidamine on electron transport in Ehrlich ascites tumor mitochondria. Arch Biochem Biophys 226:73–83, 1983
Floridi A, Paggi MG, Marcante ML, Silvestrini B, Caputo A, De Martino C: Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells. J Natl Cancer Inst 66:477–479, 1981
Floridi A, Paggi MG, D'Atri S, De Martino C, Marcante ML, Silvestrini B, Caputo A: Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Cancer Res 41:4661–4666, 1981
Scott DBM, Morris AL, Reiskin AB, Pakoskey AM: Carcinogenesis in the hamster cheek pouch. II Changes in enzymes of glucose-6-phosphate oxidation. Cancer Res 22:857–866, 1962
Scott DMB, Pakoskey AM, Sanford KKJ: Analysis of enzymatic activities of clones derived from variant cell lines transformed to malignant cells in tissue culture. J Natl Cancer Inst 25:1365–1369, 1960
Lange CFJ, Kohn P: Hexokinase specificity of some tumor tissue extracts. Cancer Res 21:1055–1061, 1961
Perria L, Viale GL, Ibba F, Andreussi L, Viale E: Istochimica dei tumooi endocranici. Neuropsichiatria 20:3–10, 1964
Timperley WR: Glycolysis in neuroectodermal tumours, in: Thomas DGT & Graham DI (eds) Brain Tumours: scientific basis, clinical investigation and current therapy, Butterworths, London, 1980, pp 145–167
Greco C, Candiloro A, Caputo A, Carapella CM, Giovanella B, Riccio A, Silvestrini B, Zupi G: Characterization and chemosensitivity of two human glioma derived cell lines. Proc AACR 27:98, 1986
Hohorst HJ: Determination with lactic-dehydrogenase and DPN, in: Bergmeyer HU (ed) Methods of enzymatic analysis. Acad Press Inc., New York, 1965, pp 226–270
Parry DM, Pedersen PL: Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. Evidence for an outer mitochondrial membrane location. J Biol Chem 258:10904–10912, 1983
Kornblith PL, Cummins CJ, Smith BH, Brooks RA, Patronas NJ, Di Chiro G: Correlation of experimental and clinical studies of metabolism by PET scanning. Prog Exp Tumor Res 27:170–178, 1984
Paggi MG, Zupi G, Fanciulli M, Del Carlo C, Giorno S, Laudonio N, Silvestrini B, Caputo A, Floridi A: Effect of lonidamine on 14C-labeled glucose by human astrocytoma cells. Exp Mol Path 47:154–165, 1987
Bustamante E, Morris HP, Pedersen PL: Hexokinase. The direct link between mitochondrial and glycolytic reaction in rapidly growing cancer cells. Adv Exp Med Biol 92:363–380, 1972
Wilson JE: Brain hexokinase. The prototype ambiquitous enzyme. Curr Thp Cell Regul 16:1–54, 1980
Purich DL, Fromm HJ, Rudolph FB: The hexokinases: kinetic, physical and regulatory properties. Adv Enzymol 39:249–326, 1973
Ballatori N, Cohen JJ: Intracellular distribution of hexokinase in the tissue zones of rat kidney. Biochem Biophys Acta 657:448–456, 1981
Bessman SP, Geiger PJ: Compartmentation of hexokinase and creatine phophokinase, cellular regulation and insulin action. Curr Top Cell Regul 16:55–86, 1980
Paggi MG, De Santis R, Floridi A, Chersi A, Tecce R, Marcante ML, Pedersen PL: Characterization of AS-30D rat hepatoma mitochondrially-bound hexokinase isozymes, in: Galeotti T, Cittadini A, Neri G, Papa S, Smets LA (eds) Cell membranes and cancer, Elsevier, Amsterdam, 1985, pp 203–208
Lusk JA, Manthorpe CM, Kao-Jen J, Wilson JE: Predominance of the cytoplasmatic form of brain hexokinase in cultured astrocytes. J Neurochem 34:1412–1420, 1980
Carapella CM, Paggi MG, Cattani F, Ciottoli GB, Floridi A, Jandolo B, Raus L, Riccio A, Caputo A: The potential role of Lonidamine in the treatment of malignant glioma. Phase II study. J Neuro-oncol, submitted.
Author information
Authors and Affiliations
Additional information
Work performed as part of CNR Research Project ‘Oncologia’, grant n. 86.00662.44 and partially supported by Associazione Italiana Ricerca sul Cancro, grant AIRC/86.
Rights and permissions
About this article
Cite this article
Paggi, M.G., Carapella, C.M., Fanciulli, M. et al. Effect of lonidamine on human malignant gliomas: Biochemical studies. J Neuro-Oncol 6, 203–209 (1988). https://doi.org/10.1007/BF00163702
Issue Date:
DOI: https://doi.org/10.1007/BF00163702